Clinical Trial Update: Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating cyclosporine ophthalmic emulsion for prevention and treatment of dry eye symptoms after LASIK or photorefractive keratectomy. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• Cyclosporine ophthalmic emulsion (Cyclosporine)

Snippet

Sponsor: Innovative Medical | Conditions: Dry Eye Syndromes | Phase 4 | Status: COMPLETED